Rebecca Ashfield, University of Oxford and Pedro Folegatti, University of Oxford Of the hundreds of potential COVID-19 vaccines in development, six are in the final stages of testing, known as phase 3 clinical trials. One of these – ChAdOx1 nCoV-19 – is the vaccine we’re developing at the University of Oxford. To be approved, vaccines need to go through multiple …
Read More »